Titre : Besoin impérieux

Besoin impérieux : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prostatic Neoplasms
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Besoin impérieux : Questions médicales les plus fréquentes", "headline": "Besoin impérieux : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Besoin impérieux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-02", "dateModified": "2025-02-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Besoin impérieux" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Pulsion", "url": "https://questionsmedicales.fr/mesh/D004328", "about": { "@type": "MedicalCondition", "name": "Pulsion", "code": { "@type": "MedicalCode", "code": "D004328", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F01.658.293" } } }, "about": { "@type": "MedicalCondition", "name": "Besoin impérieux", "alternateName": "Craving", "code": { "@type": "MedicalCode", "code": "D066249", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michael A Sayette", "url": "https://questionsmedicales.fr/author/Michael%20A%20Sayette", "affiliation": { "@type": "Organization", "name": "Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA." } }, { "@type": "Person", "name": "Kathleen A Garrison", "url": "https://questionsmedicales.fr/author/Kathleen%20A%20Garrison", "affiliation": { "@type": "Organization", "name": "Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA." } }, { "@type": "Person", "name": "Matthew C Enkema", "url": "https://questionsmedicales.fr/author/Matthew%20C%20Enkema", "affiliation": { "@type": "Organization", "name": "Department of Psychology, University of Washington." } }, { "@type": "Person", "name": "Kevin A Hallgren", "url": "https://questionsmedicales.fr/author/Kevin%20A%20Hallgren", "affiliation": { "@type": "Organization", "name": "Department of Psychiatry, University of Washington." } }, { "@type": "Person", "name": "Mary E Larimer", "url": "https://questionsmedicales.fr/author/Mary%20E%20Larimer", "affiliation": { "@type": "Organization", "name": "Department of Psychiatry, University of Washington." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Presence of HPV in prostate tissue from patients submitted to prostate biopsy.", "datePublished": "2023-01-13", "url": "https://questionsmedicales.fr/article/36651430", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/acb371205" } }, { "@type": "ScholarlyArticle", "name": "Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.", "datePublished": "2022-09-24", "url": "https://questionsmedicales.fr/article/36253300", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clgc.2022.09.007" } }, { "@type": "ScholarlyArticle", "name": "The mendelian randomized study revealed the association of prostatitis with prostate cancer risk.", "datePublished": "2024-10-20", "url": "https://questionsmedicales.fr/article/39428439", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-76355-4" } }, { "@type": "ScholarlyArticle", "name": "Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.", "datePublished": "2023-05-26", "url": "https://questionsmedicales.fr/article/37271051", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cmpb.2023.107624" } }, { "@type": "ScholarlyArticle", "name": "Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.", "datePublished": "2023-03-14", "url": "https://questionsmedicales.fr/article/36917412", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11255-023-03531-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Comportement et mécanismes comportementaux", "item": "https://questionsmedicales.fr/mesh/D001520" }, { "@type": "ListItem", "position": 3, "name": "Pulsion", "item": "https://questionsmedicales.fr/mesh/D004328" }, { "@type": "ListItem", "position": 4, "name": "Besoin impérieux", "item": "https://questionsmedicales.fr/mesh/D066249" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Besoin impérieux - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Besoin impérieux", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Besoin impérieux", "description": "Comment diagnostiquer un besoin impérieux ?\nQuels outils sont utilisés pour le diagnostic ?\nLe besoin impérieux est-il un trouble mental ?\nQuels critères DSM sont liés au besoin impérieux ?\nPeut-on mesurer l'intensité du craving ?", "url": "https://questionsmedicales.fr/mesh/D066249?mesh_terms=Prostatic+Neoplasms&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Besoin impérieux", "description": "Quels sont les symptômes du besoin impérieux ?\nLe besoin impérieux peut-il causer de l'anxiété ?\nY a-t-il des symptômes physiques associés ?\nLe craving est-il constant ou intermittent ?\nComment le craving affecte-t-il le comportement ?", "url": "https://questionsmedicales.fr/mesh/D066249?mesh_terms=Prostatic+Neoplasms&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Besoin impérieux", "description": "Comment prévenir le besoin impérieux ?\nLes programmes de sensibilisation sont-ils efficaces ?\nLe développement de compétences aide-t-il ?\nLes groupes de soutien sont-ils utiles ?\nLa gestion des déclencheurs est-elle importante ?", "url": "https://questionsmedicales.fr/mesh/D066249?mesh_terms=Prostatic+Neoplasms&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Besoin impérieux", "description": "Quels traitements sont efficaces contre le craving ?\nLa thérapie cognitivo-comportementale aide-t-elle ?\nLes médicaments peuvent-ils réduire le craving ?\nLe soutien social est-il important dans le traitement ?\nY a-t-il des approches alternatives au traitement ?", "url": "https://questionsmedicales.fr/mesh/D066249?mesh_terms=Prostatic+Neoplasms&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Besoin impérieux", "description": "Quelles complications peuvent survenir avec le craving ?\nLe craving peut-il mener à des addictions ?\nY a-t-il des risques physiques associés au craving ?\nLe besoin impérieux affecte-t-il les relations ?\nLe craving peut-il entraîner des problèmes juridiques ?", "url": "https://questionsmedicales.fr/mesh/D066249?mesh_terms=Prostatic+Neoplasms&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Besoin impérieux", "description": "Quels sont les facteurs de risque du craving ?\nLe stress augmente-t-il le risque de craving ?\nLes troubles mentaux sont-ils des facteurs de risque ?\nL'environnement social influence-t-il le craving ?\nLes habitudes de vie jouent-elles un rôle ?", "url": "https://questionsmedicales.fr/mesh/D066249?mesh_terms=Prostatic+Neoplasms&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un besoin impérieux ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation des symptômes et des antécédents du patient." } }, { "@type": "Question", "name": "Quels outils sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des questionnaires standardisés et des entretiens cliniques sont souvent utilisés." } }, { "@type": "Question", "name": "Le besoin impérieux est-il un trouble mental ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être associé à des troubles comme l'addiction ou les troubles alimentaires." } }, { "@type": "Question", "name": "Quels critères DSM sont liés au besoin impérieux ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les critères DSM-5 pour les troubles liés à des substances incluent le craving." } }, { "@type": "Question", "name": "Peut-on mesurer l'intensité du craving ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des échelles de mesure spécifiques évaluent l'intensité du craving." } }, { "@type": "Question", "name": "Quels sont les symptômes du besoin impérieux ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent une envie intense, agitation, et parfois des symptômes physiques." } }, { "@type": "Question", "name": "Le besoin impérieux peut-il causer de l'anxiété ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le craving peut entraîner une anxiété significative chez les individus concernés." } }, { "@type": "Question", "name": "Y a-t-il des symptômes physiques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la transpiration ou des palpitations peuvent survenir." } }, { "@type": "Question", "name": "Le craving est-il constant ou intermittent ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Il peut être intermittent, souvent déclenché par des stimuli environnementaux." } }, { "@type": "Question", "name": "Comment le craving affecte-t-il le comportement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Il peut mener à des comportements compulsifs pour satisfaire l'envie." } }, { "@type": "Question", "name": "Comment prévenir le besoin impérieux ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par l'éducation, la gestion du stress et le soutien social." } }, { "@type": "Question", "name": "Les programmes de sensibilisation sont-ils efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils aident à informer sur les risques et à réduire le craving." } }, { "@type": "Question", "name": "Le développement de compétences aide-t-il ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, développer des compétences d'adaptation peut réduire le risque de craving." } }, { "@type": "Question", "name": "Les groupes de soutien sont-ils utiles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils offrent un environnement de soutien pour partager des expériences." } }, { "@type": "Question", "name": "La gestion des déclencheurs est-elle importante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, identifier et gérer les déclencheurs peut prévenir le craving." } }, { "@type": "Question", "name": "Quels traitements sont efficaces contre le craving ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les thérapies comportementales et les médicaments peuvent aider à réduire le craving." } }, { "@type": "Question", "name": "La thérapie cognitivo-comportementale aide-t-elle ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est efficace pour modifier les pensées et comportements liés au craving." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils réduire le craving ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments, comme les antidépresseurs, peuvent diminuer le craving." } }, { "@type": "Question", "name": "Le soutien social est-il important dans le traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le soutien social joue un rôle crucial dans la gestion du craving." } }, { "@type": "Question", "name": "Y a-t-il des approches alternatives au traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des approches comme la méditation et la pleine conscience peuvent être bénéfiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le craving ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles de santé mentale et des comportements à risque." } }, { "@type": "Question", "name": "Le craving peut-il mener à des addictions ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un besoin impérieux non traité peut évoluer vers une addiction sévère." } }, { "@type": "Question", "name": "Y a-t-il des risques physiques associés au craving ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le craving peut entraîner des comportements nuisibles à la santé physique." } }, { "@type": "Question", "name": "Le besoin impérieux affecte-t-il les relations ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut nuire aux relations personnelles et professionnelles." } }, { "@type": "Question", "name": "Le craving peut-il entraîner des problèmes juridiques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des comportements impulsifs liés au craving peuvent causer des problèmes juridiques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du craving ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, le stress et l'environnement social sont des facteurs clés." } }, { "@type": "Question", "name": "Le stress augmente-t-il le risque de craving ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress est un facteur majeur qui peut intensifier le besoin impérieux." } }, { "@type": "Question", "name": "Les troubles mentaux sont-ils des facteurs de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles comme l'anxiété et la dépression augmentent le risque de craving." } }, { "@type": "Question", "name": "L'environnement social influence-t-il le craving ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un environnement social négatif peut exacerber le besoin impérieux." } }, { "@type": "Question", "name": "Les habitudes de vie jouent-elles un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes de vie malsaines peuvent augmenter le risque de craving." } } ] } ] }

Sources (10000 au total)

Presence of HPV in prostate tissue from patients submitted to prostate biopsy.

Prostate cancer (PCa) is the second most frequent cancer among men in the Western population. Infections, such as the one caused by the human papillomavirus (HPV), have been shown to promote inflammat... Prostate tissue fragments were collected by prostate biopsy and subjected to polymerase chain reaction with primers for the HPV L1 gene to identify the presence of the virus.... Among 162 patients, 10 (6.2%) had HPV and in 152 (93.8%) HPV was not identified in prostate biopsies. HPV was detected in 7/95 (7.4%) of patients with PCa, in 2/55 (3.6%) of patients without PCa, and ... There were no significant levels of HPV L1 protein in prostate tissue. The findings suggest the absence of HPV oncogenic activity in the prostate tissue of patients with PCa....

Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.

In this study, it was aimed to investigate the reliability of total prostate-specific antigen (t-PSA) in prostate cancer screening in hyperglycemic (≥126 mg/dL) individuals.... This research was planned as a cross-sectional retrospective study. Three hundred eleven cases which underwent biopsy with the suspicion of prostate cancer in the hospital were included in the study. ... It was determined that the t-PSA measurement was higher in the patient group with cancer (P < .001). It was determined that the median t-PSA levels of the intermediate and high cancer groups were high... As a contribution to literature, we found that the t-PSA test lost its sensitivity in cases with plasma glucose levels above normal. Loss of sensitivity may result in underdiagnosis in prostate cancer...

Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.

With emerging evidence to improve prostate cancer (PCa) screening, multiparametric magnetic prostate imaging is becoming an essential noninvasive component of the diagnostic routine. Computer-aided di... We collected 1647 fine-grained biopsy-confirmed findings, including Gleason scores and prostatitis, to form a training dataset. In our experimental framework for lesion detection, all models utilized ... An optimal model configuration with fine class granularity (prostatitis included) and OHE has scored the lesion-wise partial Free-Response Receiver Operating Characteristic (FROC) area under the curve... This paper examines several configurations for model training in the biparametric MRI setup and proposes optimal value ranges. It also shows that the fine-grained class configuration, including prosta...

Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.

To assess the efficacy of 2-core prostate biopsy in advanced prostate cancer patients. This included a retrospective analysis of 12-core prostate biopsies and a prospective validation that a reduced n... The first phase analyzed retrospective data from 12-core prostate biopsies between January 2013 and 2018. In the second phase, from January 2018 to January 2022, in a prospective setting, patients wit... In the retrospective analysis, the number of positive cores in metastatic disease was 12 in 93 (73.8%), 11 in 14 (11.1%), and 10 in 7 (5.6%) patients. Using probability analysis, 94% of patients with ... A 2-core biopsy is adequate in almost all patients with metastatic prostate cancer with PSA > 75, and this avoids excess complications and morbidity associated with a systematic 12-core prostate biops...

Prostate cancer aggressiveness and financial toxicity among prostate cancer patients.

Financial toxicity (FT) is a growing concern among cancer survivors that adversely affects the quality of life and survival. Individuals diagnosed with aggressive cancers are often at a greater risk o... PCa patients enrolled in the North Carolina-Louisiana Prostate Cancer Project (PCaP) were recontacted for long-term follow-up. The prevalence of FT in the PCaP cohort was estimated. FT was estimated u... More than one-third of PCa patients reported experiencing FT. PCa aggressiveness was significantly independently associated with high FT; high aggressive PCa at diagnosis had more than twice the risk ... Aggressive PCa was associated with high FT. Future studies should collect more information about the characteristics of men with high FT and identify additional risk factors of FT....

Is prostatic adenocarcinoma with cribriform architecture more difficult to detect on prostate MRI?

Cribriform (CBFM) pattern on prostate biopsy has been implicated as a predictor for high-risk features, potentially leading to adverse outcomes after definitive treatment. This study aims to investiga... Patients who underwent multiparametric magnetic resonance imaging (mpMRI), combined 12-core transrectal ultrasound (TRUS) guided systematic (SB) and MRI/US fusion-guided biopsy were retrospectively qu... Between 2015 and 2022, a total of 131 consecutive patients with CBFM pattern on prostate biopsy and pre-biopsy mpMRI were included. Clinical feature analysis included 1572 systematic biopsy cores (114... The extent of disease for CBFM-containing tumors is difficult to capture on mpMRI. When comparing MRI lesions of similar dimensions and PIRADS scores, CBFM-containing tumors appear to have larger canc...